📢 #PortfolioNews | Excited to share the strategic deal of our #portfolio company #VarmX with #CSL 💊
🔹Up to $2.2B incl. $117m upfront & milestones
🔹Global Phase 3 of VMX-C001 fully funded
🌍Step closer to market for a major unmet need
👉 buff.ly/aO4iHwV
#YsiosPortfolio #vc
🔹Up to $2.2B incl. $117m upfront & milestones
🔹Global Phase 3 of VMX-C001 fully funded
🌍Step closer to market for a major unmet need
👉 buff.ly/aO4iHwV
#YsiosPortfolio #vc
September 16, 2025 at 10:08 AM
📢 #PortfolioNews | Excited to share the strategic deal of our #portfolio company #VarmX with #CSL 💊
🔹Up to $2.2B incl. $117m upfront & milestones
🔹Global Phase 3 of VMX-C001 fully funded
🌍Step closer to market for a major unmet need
👉 buff.ly/aO4iHwV
#YsiosPortfolio #vc
🔹Up to $2.2B incl. $117m upfront & milestones
🔹Global Phase 3 of VMX-C001 fully funded
🌍Step closer to market for a major unmet need
👉 buff.ly/aO4iHwV
#YsiosPortfolio #vc
#PortfolioNews I Our #portfolio company ONA Therapeutics strengthens leadership to accelerate first-in-class #ADCs targeting resistant #cancer cells & advancing toward #clinical development.
📢 Read more here https://buff.ly/4gK9vh3
#Oncology #Biotech #Pharma #YsiosPortfolio
📢 Read more here https://buff.ly/4gK9vh3
#Oncology #Biotech #Pharma #YsiosPortfolio
February 20, 2025 at 9:02 AM
#PortfolioNews I Our #portfolio company ONA Therapeutics strengthens leadership to accelerate first-in-class #ADCs targeting resistant #cancer cells & advancing toward #clinical development.
📢 Read more here https://buff.ly/4gK9vh3
#Oncology #Biotech #Pharma #YsiosPortfolio
📢 Read more here https://buff.ly/4gK9vh3
#Oncology #Biotech #Pharma #YsiosPortfolio